Computational Analysis of Single Nucleotide Polymorphisms in Human HIC1 Gene

被引:0
作者
Annanya, Arora [1 ]
Priyadharshini, Boopathi [2 ]
Suresh, Vasugi [3 ]
Dilipan, Elangovan [2 ]
机构
[1] Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci SIMATS, Physiol, Chennai, India
[2] Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Physiol, Chennai, India
[3] Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Med Physiol, Chennai, India
关键词
wnt signaling pathway; cancer protein; hic1; gene; single nucleotide polymorphism; in silico analysis; TUMOR-SUPPRESSOR GENE; IN-SILICO ANALYSIS; METHYLATION; SNPS;
D O I
10.7759/cureus.56664
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A putative tumor suppressor gene called HIC1 (hypermethylated in cancer) is situated at 17p13.3, a locus where the allelic loss occurs often in human malignancies, including breast cancer. Hypermethylated in cancer 1 protein is a protein that in humans is encoded by the HIC1 gene and it's a Homo sapiens (Human). This gene functions as a growth regulatory and tumor repressor gene. The molecular function of HIC1 gene includes DNA-binding transcription factor activity, sequence-specific DNA binding, DNA binding, histone deacetylase binding, protein binding, metal ion binding, nucleic acid binding, DNA-binding transcription repressor activity, RNA polymerase II-specific, DNA-binding transcription factor activity, RNA polymerase II-specific. The biological process of HIC1 gene includes multicellular organism development, negative regulation of Wnt signaling pathway, positive regulation of DNA damage response, signal transduction by p53 class mediator regulation of transcription, DNA-templated, negative regulation of transcription by RNA polymerase II, Wnt signaling pathway, transcription, DNA-templated, intrinsic apoptotic signaling pathway in response to DNA damage, cellular response to DNA damage stimulus. The study aimed to predict the stability and structure of the protein that will arise from single nucleotide polymorphisms (SNPs) in the human HIC1 gene. Methodology To investigate the possible negative effects associated with these SNPs, bioinformatic analysis is typically essential. The following tools were employed for forecasting harmful SNPs: scale-invariant feature transform (SIFT), Protein Analysis Through Evolutionary Relationships (PANTHER), nonsynonymous SNP by Protein Variation Effect Analyzer (PROVEAN), and nonsynonymous SNP by Single Nucleotide Polymorphism Annotation Platform (SNAP). Results The present study identified a total of 36 SNPs using the SIFT approach, which were shown to have functional significance. Twenty-six were determined to be tolerable, whereas 10 were shown to be detrimental. Out of 20 SNPs, seven (P370A, P646S, R654P, A476T, S400S, D666N, D7V) SNPs were predicted as "Possibly damaging" and seven (L9F, G468R, G490R, L482R, S12W, G489D, S12P) were identified as "probably benign", and six (R725G, G620S, A56V, E463D, D394N, L338V) were identified as "probably damaging" according to the predictions made by PANTHER tools. The majority of the pixels on the strip were red, indicating that the gene changes may have dangerous consequences. These results highlight the need for more research to fully comprehend how these mutations affect the hic1 protein's function, which is essential for the emergence of different types of cancer. Conclusion The current research has provided us with essential information about how SNPs might be used as a diagnostic marker for cancer, given that SNPs may be candidates for cellular changes caused by mutations linked to cancer.
引用
收藏
页数:8
相关论文
共 29 条
  • [1] In silico screening of non-synonymous SNPs in human TUFT1 gene
    Ajith, Athira
    Subbiah, Usha
    [J]. JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2023, 21 (01)
  • [2] In Silico Analysis of Single Nucleotide Polymorphism (SNPs) in Human β-Globin Gene
    Alanazi, Mohammed
    Abduljaleel, Zainularifeen
    Khan, Wajahatullah
    Warsy, Arjumand S.
    Elrobh, Mohamed
    Khan, Zahid
    Al Amri, Abdullah
    Bazzi, Mohammad D.
    [J]. PLOS ONE, 2011, 6 (10):
  • [3] Predicting the effects of rare genetic variants on oncogenic signaling pathways: A computational analysis of HRAS protein function
    Ali, Sadaqat
    Ali, Usman
    Qamar, Adeem
    Zafar, Imran
    Yaqoob, Muhammad
    Ain, Qurat ul
    Rashid, Summya
    Sharma, Rohit
    Nafidi, Hiba-Allah
    Bin Jardan, Yousef A.
    Bourhia, Mohammed
    [J]. FRONTIERS IN CHEMISTRY, 2023, 11
  • [4] Identification of Functional SNPs in BARD1 Gene and In Silico Analysis of Damaging SNPs: Based on Data Procured from dbSNP Database
    Alshatwi, Ali A.
    Hasan, Tarique N.
    Syed, Naveed A.
    Shafi, Gowhat
    Grace, B. Leena
    [J]. PLOS ONE, 2012, 7 (10):
  • [5] Identification and in silico analysis of functional SNPs of human TAGAP protein: A comprehensive study
    Arshad, Maria
    Bhatti, Attya
    John, Peter
    [J]. PLOS ONE, 2018, 13 (01):
  • [6] Computational Exploration of Single-Nucleotide Polymorphisms in the Human hRAS Gene: Implications and Insights
    Dakshitha, Sankar
    Dharshini, Boopathi Priya
    Suresh, Vasugi
    Dilipan, Elangovan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [7] The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif
    Deltour, S
    Pinte, S
    Guerardel, C
    Wasylyk, B
    Leprince, D
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (13) : 4890 - 4901
  • [8] Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1
    Deltour, S
    Pinte, S
    Guérardel, C
    Leprince, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (02) : 427 - 434
  • [9] HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors
    Fleuriel, Capucine
    Touka, Majid
    Boulay, Gaylor
    Guerardel, Cateline
    Rood, Brian R.
    Leprince, Dominique
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (01) : 26 - 33
  • [10] Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
    Fujii, H
    Biel, MA
    Zhou, WB
    Weitzman, SA
    Baylin, SB
    Gabrielson, E
    [J]. ONCOGENE, 1998, 16 (16) : 2159 - 2164